These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10840305)

  • 1. Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation.
    Myung SJ; Kim MH; Kim YS; Kim HJ; Park ET; Yoo KS; Lim BC; Wan Seo D; Lee SK; Min YI; Kim JY
    Gastrointest Endosc; 2000 Jun; 51(6):708-13. PubMed ID: 10840305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
    Uehara H; Nakaizumi A; Tatsuta M; Baba M; Takenaka A; Uedo N; Sakai N; Yano H; Iishi H; Ohigashi H; Ishikawa O; Okada S; Kakizoe T
    Am J Gastroenterol; 1999 Sep; 94(9):2513-8. PubMed ID: 10484017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of K-ras point mutation and telomerase activity during endoscopic retrograde cholangiopancreatography in diagnosis of pancreatic cancer.
    Zhou GX; Huang JF; Li ZS; Xu GM; Liu F; Zhang H
    World J Gastroenterol; 2004 May; 10(9):1337-40. PubMed ID: 15112354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
    Seki K; Suda T; Aoyagi Y; Sugawara S; Natsui M; Motoyama H; Shirai Y; Sekine T; Kawai H; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Asakura H
    Clin Cancer Res; 2001 Jul; 7(7):1976-81. PubMed ID: 11448913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer.
    Boadas J; Mora J; Urgell E; Puig P; Roca M; Cussó X; Capellà G; Lluís F; Farré A
    Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1153-9. PubMed ID: 11711770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice.
    Uehara H; Nakaizumi A; Baba M; Iishi H; Tatsuta M; Kitamura T; Ohigashi H; Ishikawa O; Takenaka A; Ishiguro S
    Am J Gastroenterol; 1996 Aug; 91(8):1616-21. PubMed ID: 8759672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic diagnosis of pancreatic cancer.
    Mizumoto K; Tanaka M
    J Hepatobiliary Pancreat Surg; 2002; 9(1):39-44. PubMed ID: 12021896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [K-ras mutation in pancreatic juice from patients with pancreatic carcinoma].
    Gong X; Chen Y; Chen Y; Lu X
    Zhonghua Nei Ke Za Zhi; 1999 Oct; 38(10):673-6. PubMed ID: 11798705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer.
    Lu X; Xu T; Qian J; Wen X; Wu D
    Chin Med J (Engl); 2002 Nov; 115(11):1632-6. PubMed ID: 12609076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice.
    Queneau PE; Adessi GL; Thibault P; Cléau D; Heyd B; Mantion G; Carayon P
    Am J Gastroenterol; 2001 Mar; 96(3):700-4. PubMed ID: 11280537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An application value of detecting K-ras and p53 gene mutation in the stool and pure pancreatic juice for diagnosis of early pancreatic cancer].
    Lu X; Xu T; Qian J
    Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(17):1050-3. PubMed ID: 11758254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer.
    Berthélemy P; Bouisson M; Escourrou J; Vaysse N; Rumeau JL; Pradayrol L
    Ann Intern Med; 1995 Aug; 123(3):188-91. PubMed ID: 7598300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: cytologic studies and k-ras-2 codon 12 molecular analysis in 47 cases.
    Pugliese V; Pujic N; Saccomanno S; Gatteschi B; Pera C; Aste H; Ferrara GB; Nicolò G
    Gastrointest Endosc; 2001 Nov; 54(5):595-9. PubMed ID: 11677475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does detection of K-ras mutations in pancreatic juice influence clinical decision making?
    O'Mahony S; Sreedharan A
    Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1141-2. PubMed ID: 11711767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy.
    Nakaizumi A; Uehara H; Takenaka A; Uedo N; Sakai N; Yano H; Ohigashi H; Ishikawa O; Ishiguro S; Sugano K; Tatsuta M
    Hepatogastroenterology; 1999; 46(25):31-7. PubMed ID: 10228761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma.
    Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y
    Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.
    Suehara N; Mizumoto K; Tanaka M; Niiyama H; Yokohata K; Tominaga Y; Shimura H; Muta T; Hamasaki N
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2479-83. PubMed ID: 9815650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
    Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
    Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis.
    Löhr M; Müller P; Mora J; Brinkmann B; Ostwald C; Farré A; Lluis F; Adam U; Stubbe J; Plath F; Nizze H; Hopt UT; Barten M; Capellá G; Liebe S
    Gastrointest Endosc; 2001 Jun; 53(7):734-43. PubMed ID: 11375580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer.
    Suehara N; Mizumoto K; Kusumoto M; Niiyama H; Ogawa T; Yamaguchi K; Yokohata K; Tanaka M
    Am J Gastroenterol; 1998 Oct; 93(10):1967-71. PubMed ID: 9772067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.